All TEAM Occupancy from Tropical mammal functional diversity increases with productivity but decreases with anthropogenic disturbance حسب Daniel Gorczynski (10093617)

"…Mammal community functional dispersion increased with primary productivity, while functional richness decreased with human-induced local extinctions and was significantly lower in Madagascar than other tropical regions. …"

Changes in urinary 8-OHdG, L-FABP and creatinine levels in each HFrEF and HFpEF patients (FAS). حسب Masashi Sakuma (3923087)

الموضوعات:

Changes in NT-proBNP, LVEF, E/e’ (FAS), and TRPG (PPS) in each HFrEF and HFpEF patients. حسب Masashi Sakuma (3923087)

الموضوعات:

Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Stacked bar showing the frequency and mode changes of ten activities (6–10) across 7 phases; the modes in phase 0 were assumed to be all doing in-person. حسب Lan Li (73597)

الموضوعات:

Stacked bar showing the frequency and mode changes of ten activities (1–5) across 7 phases; the modes in phase 0 were assumed to be all doing in-person. حسب Lan Li (73597)

الموضوعات:

Image 2_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.jpeg حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Image 1_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.jpeg حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Table 2_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.docx حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Image 4_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.jpeg حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Table 1_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.docx حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Image 5_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.jpeg حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Image 3_Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis.jpeg حسب Yue Zhang (30585)

"…However, CV mortality was not significantly reduced in HFmrEF/HFpEF patients (HR: 0.92, 95% CI: 0.82–1.02, P = 0.13), but was reduced by 23% in HFrEF patients (HR: 0.77, 95% CI: 0.70–0.83, P < 0.00001). …"

Total and resource-specific absolute costs (in 2020 CAD) per quarter in 2020 and percentage change from 2018 and 2019 for all individuals in Ontario. حسب Seraphine Zeitouny (16954499)

الموضوعات:

Outline of study visits. حسب Jordan K. Abbott (8934239)

الموضوعات:

S18 Fig - حسب Jordan K. Abbott (8934239)

الموضوعات:

S15 Fig - حسب Jordan K. Abbott (8934239)

الموضوعات:

S2 Fig - حسب Jordan K. Abbott (8934239)

الموضوعات:

S4 Fig - حسب Jordan K. Abbott (8934239)

الموضوعات:

S14 Fig - حسب Jordan K. Abbott (8934239)

الموضوعات: